Novartis
Industry
Pharmaceuticals
Corporate Headquarters
Basel, Switzerland
Corporate Profits, 2005-2024
$288.2 billion
Find an oligarch
Spending Snapshot
Campaign Spending
$17.9million
From Employees: 0.1%
Lobbying Spending
$4.7million
Total Political Spending
$22.6million
Issues
- Spent $7.9 million to oppose Prop. 79 (Defeated, 2005) (and support the competing Prop. 78 (Defeated, 2005)) to prevent the reduction of prescription drug prices
- Spent $6.6 million to oppose Prop. 61 (Defeated, 2016), which would have reduced prescription drug prices
- Lobbied against numerous bills that sought to ensure the safety, effectiveness, and affordability of prescription drugs, including: AB-71 (Defeated, 2005-06), AB-75 (Defeated, 2005-06), AB-76 (Vetoed, 2005-06), AB-2690 (Defeated, 2007-08)
- Gave $1.2 million to committees advancing the overall agenda of the Pharmaceutical Research and Manufacturers Association
- Gave $1.2 million to committees advancing the overall agenda of the Pharmaceutical Research and Manufacturers Association
- Gave $1.2 million to committees advancing the overall agenda of the Pharmaceutical Research and Manufacturers Association
- Gave $1.2 million to committees advancing the overall agenda of the Pharmaceutical Research and Manufacturers Association
- Gave $1.2 million to committees advancing the overall agenda of the Pharmaceutical Research and Manufacturers Association
- Gave $1.2 million to committees advancing the overall agenda of the Pharmaceutical Research and Manufacturers Association
Republicans
$108.9k
Democrats
$399.6k
Total - All Current Elected Officials
$510.0k
Along with contributing directly to political campaigns and other efforts to support particular candidates, California’s top oligarchs and their allies make significant donations to other political action committees (PACs). These PACs often then use those funds to contribute to various political campaigns.
Listed below are the major contributions ($100K+) made by Novartis to PACs that have contributed to current state-level elected officials, as well as all $10K+ contributions made to current state-level elected officials. Although these contributions were not made directly by Novartis to the elected official, they reflect potential indirect financial ties that can also result in political influence.
Along with contributing directly to political campaigns, California’s top oligarchs and their allies make significant donations to other political action committees (PACs) that oppose various political campaigns.
Listed below are the major contributions ($100K+) made by Novartis to PACs that have opposed current state-level elected officials, as well as all $10K+ contributions made in opposition to current state-level elected officials.
Although these contributions were not made directly by Novartis to oppose to the elected officials, they reflect potential indirect financial influence.
Pharmaceutical Research and Manufacturers of America California Initiative Fund: OPPOSED: PROP 79 - PRESCRIPTION DRUG DISCOUNTS. STATE-NEGOTIATED REBATES. | SUPPORTED: PROP 78 - PRESCRIPTION DRUGS. DISCOUNTS.
$7.9 million
No on Prop 61 - Californians Against the Deceptive Rx Proposition, a Coalition of Veterans Doctors Patient Advocates Seniors Taxpayers and Members of Pharmaceutical Research and Manufacturers of America: OPPOSED: PROPOSITION 061- STATE PRESCRIPTION DRUG PURCHASES. PRICING STANDARDS.
$6.6 million
Pharmaceutical Research and Manufacturers of America Independent Expenditure Committee
$1.1 million
Pharmaceutical Research and Manufacturers Association of America PAC
$150.2k
Californians for Jobs and a Strong Economy
$134.1k
California Republican Party
$102.4k
